or
forgot password
  • cancer clinical trials in portland, OR

  • Early or Delayed Fludarabine and Rituximab in Treating Patients With Previously Untreated Chronic Lymphocytic Leukemia
    Providence Cancer Center at Providence Portland Medical Center

    Trial Locations
    Providence Cancer Center at Providence Portland Medical Center
    Providence St. Vincent Medical Center
    Leukemia
    Baclofen-Amitriptyline Hydrochloride-Ketamine Gel in Treating Peripheral Neuropathy Caused by Chemotherapy in Patients With Cancer
    Providence Cancer Center at Providence Portland Medical Center

    Trial Locations
    Providence Cancer Center at Providence Portland Medical Center
    Providence St. Vincent Medical Center
    Adventist Medical Center
    Legacy Good Samaritan Hospital & Comprehensive Cancer Center
    Chronic Myeloproliferative Disorders, Leukemia, Lymphoma, Lymphoproliferative Disorder, Multiple Myeloma and Plasma Cell Neoplasm, Myelodysplastic Syndromes, Myelodysplastic/Myeloproliferative Neoplasms, Neurotoxicity, Pain, Unspecified Adult Solid Tumor, Protocol Specific
    First-Line Chemotherapy and Trastuzumab With or Without Bevacizumab in Treating Patients With Metastatic Breast Cancer That Overexpresses HER-2/NEU
    Providence Portland Medical Center

    Trial Locations
    Providence Portland Medical Center
    Providence Saint Vincent Medical Center
    Columbia River Oncology Program
    HER2-positive Breast Cancer, Male Breast Cancer, Recurrent Breast Cancer, Stage IV Breast Cancer
    Carboplatin, Paclitaxel and Gemcitabine With or Without Bevacizumab After Surgery in Treating Patients With Recurrent Ovarian Epithelial Cancer, Primary Peritoneal Cavity Cancer, or Fallopian Tube Cancer
    Oregon Health and Science University

    Trial Locations
    Oregon Health and Science University
    Northwest Cancer Specialists-Rose Quarter Cancer Center
    Brenner Tumor, Fallopian Tube Cancer, Ovarian Clear Cell Cystadenocarcinoma, Ovarian Endometrioid Adenocarcinoma, Ovarian Mixed Epithelial Carcinoma, Ovarian Mucinous Cystadenocarcinoma, Ovarian Serous Cystadenocarcinoma, Ovarian Undifferentiated Adenocarcinoma, Primary Peritoneal Cavity Cancer, Recurrent Ovarian Epithelial Cancer
    Octreotide Acetate and Recombinant Interferon Alfa-2b or Bevacizumab in Treating Patients With Metastatic or Locally Advanced, High-Risk Neuroendocrine Tumor
    Providence Portland Medical Center

    Trial Locations
    Providence Portland Medical Center
    Kaiser Permanente
    Providence Saint Vincent Medical Center
    Columbia River Oncology Program
    Neuroendocrine Carcinoma
    Tamoxifen Citrate or Letrozole With or Without Bevacizumab in Treating Women With Stage III or Stage IV Breast Cancer
    Adventist Medical Center

    Trial Locations
    Adventist Medical Center
    Providence Portland Medical Center
    Kaiser Permanente
    Providence Saint Vincent Medical Center
    Columbia River Oncology Program
    Recurrent Breast Cancer, Stage IIIB Breast Cancer, Stage IV Breast Cancer
    Melphalan, Prednisone, and Thalidomide or Lenalidomide in Treating Patients With Newly Diagnosed Multiple Myeloma
    Legacy Good Samaritan Hospital and Medical Center

    Trial Locations
    Legacy Good Samaritan Hospital and Medical Center
    Northwest Cancer Specialists-Rose Quarter Cancer Center
    Stage I Multiple Myeloma, Stage II Multiple Myeloma, Stage III Multiple Myeloma
    BETH Study: Treatment of HER2 Positive Breast Cancer With Chemotherapy Plus Trastuzumab vs Chemotherapy Plus Trastuzumab Plus Bevacizumab
    Providence St. Vincent Medical Center

    Trial Locations
    Providence St. Vincent Medical Center
    Adventist Medical Center
    Providence Portland Medical Center
    CCOP, Columbia River Oncology
    Northwest Cancer Specialists-Adventist Office
    Northwest Cancer Specialists-Portland
    Providence Oncology and Hematology Care Clinic
    Breast Cancer
    Defibrotide for Patients With Hepatic Veno-occlusive Disease: A Treatment IND Study
    Oregon Health and Science University
    Portland, Oregon 97201
    Hepatic Veno-Occlusive Disease
    Isavuconazole in the Treatment of Renally Impaired Aspergillosis and Rare Fungi
    Oregon Health & Science University
    Portland, Oregon 97201
    Aspergillosis, Invasive Fungal Infections
    Erlotinib and Chemotherapy for 2nd Line Treatment (Tx) of Metastatic Colorectal Cancer (mCRC)
    Oregon Health & Science University
    Portland, Oregon 97201
    Metastatic Colorectal Cancer
    Efficacy and Safety Study of Apixaban for the Treatment of Deep Vein Thrombosis or Pulmonary Embolism
    Oregon Health Science University
    Portland, Oregon 97239
    Venous Thrombosis
    Lenalidomide and Dexamethasone With or Without Bortezomib in Treating Patients With Previously Untreated Multiple Myeloma
    Legacy Emanuel Hospital and Health Center

    Trial Locations
    Legacy Emanuel Hospital and Health Center
    Providence Portland Medical Center
    Legacy Good Samaritan Hospital and Medical Center
    Northwest Cancer Specialists-Rose Quarter Cancer Center
    Providence Saint Vincent Medical Center
    Columbia River Oncology Program
    Stage I Multiple Myeloma, Stage II Multiple Myeloma, Stage III Multiple Myeloma
    Focusing Implementation to Bring Effective Reminders (FIBER)
    Kaiser Permanente Center for Health Research
    Portland, Oregon 97227-1098
    Colorectal Cancer
    Azacitidine and Gemtuzumab Ozogamicin in Treating Older Patients With Previously Untreated Acute Myeloid Leukemia
    Providence Portland Medical Center

    Trial Locations
    Providence Portland Medical Center
    Providence Saint Vincent Medical Center
    Columbia River Oncology Program
    Adult Acute Megakaryoblastic Leukemia (M7), Adult Acute Monoblastic Leukemia (M5a), Adult Acute Monocytic Leukemia (M5b), Adult Acute Myeloblastic Leukemia With Maturation (M2), Adult Acute Myeloblastic Leukemia Without Maturation (M1), Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities, Adult Acute Myeloid Leukemia With Inv(16)(p13;q22), Adult Acute Myeloid Leukemia With t(16;16)(p13;q22), Adult Acute Myeloid Leukemia With t(8;21)(q22;q22), Adult Acute Myelomonocytic Leukemia (M4), Adult Erythroleukemia (M6a), Adult Pure Erythroid Leukemia (M6b), Secondary Acute Myeloid Leukemia, Untreated Adult Acute Myeloid Leukemia
    Safety Study of AP24534 to Treat Chronic Myelogenous Leukemia (CML) and Other Hematological Malignancies
    ARIAD Investigational Site #048
    Portland, Oregon 97239
    Chronic Myelogenous Leukemia, Hematologic Malignancies
    Mitoxantrone ± Cetuximab 2nd Line Androgen Independent Prostate Cancer (AIPC)
    Oregon Health & Science University
    Portland, Oregon 97201
    Androgen-independent Prostate Cancer
    Aerobic Exercise, Resistance Exercise, or Flexibility and Relaxation Training in Inactive Older Female Breast Cancer Survivors
    Knight Cancer Institute at Oregon Health and Science University
    Portland, Oregon 97239-3098
    Breast Cancer, Cancer Survivor, Fatigue, Long-term Effects Secondary to Cancer Therapy in Adults, Psychosocial Effects of Cancer and Its Treatment
    EZN-2285 or Pegaspargase and Combination Chemotherapy in Treating Younger Patients With Newly Diagnosed High-Risk Acute Lymphoblastic Leukemia
    Knight Cancer Institute at Oregon Health and Science University
    Portland, Oregon 97239-3098
    Leukemia
    Evaluating Dactinomycin and Vincristine in Young Patients With Cancer
    Knight Cancer Institute at Oregon Health and Science University
    Portland, Oregon 97239-3098
    Kidney Cancer, Leukemia, Sarcoma, Unspecified Childhood Solid Tumor, Protocol Specific
    Capecitabine and Lapatinib With or Without Cixutumumab in Treating Patients With Previously Treated HER2-Positive Stage IIIB, Stage IIIC, or Stage IV Breast Cancer
    Providence Portland Medical Center

    Trial Locations
    Providence Portland Medical Center
    Providence Saint Vincent Medical Center
    Columbia River Oncology Program
    HER2-positive Breast Cancer, Male Breast Cancer, Recurrent Breast Cancer, Stage IIIB Breast Cancer, Stage IIIC Breast Cancer, Stage IV Breast Cancer